NCT02892409View on ClinicalTrials.gov

TAK-438 Bismuth Drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 5, 2016

Primary Completion Date

April 17, 2017

Study Completion Date

May 11, 2017

Conditions
Helicobacter Pylori
Interventions
DRUG

Clarithromycin

Clarithromycin tablets

DRUG

Amoxicillin

Amoxicillin capsules

DRUG

Tripotassium bismuth dicitrate

Tripotassium bismuth dicitrate tablets

DRUG

Lansoprazole

Lansoprazole capsules

DRUG

TAK-438

TAK-438 tablets

Trial Locations (1)

Unknown

Seoul

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY